BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cao LB, Jones C, Movahed A. Low ADAMTS-13 in plavix induced thrombotic thrombocytopenic purpura. World J Clin Cases 2013; 1(1): 31-33 [PMID: 24303458 DOI: 10.12998/wjcc.v1.i1.31]
URL: https://www.wjgnet.com/2307-8960/full/v1/i1/31.htm
Number Citing Articles
1
Marley J. Binder, Scott McCoombe, Elizabeth D. Williams, Daniel R. McCulloch, Alister C. Ward. The extracellular matrix in cancer progression: Role of hyalectan proteoglycans and ADAMTS enzymesCancer Letters 2017; 385: 55 doi: 10.1016/j.canlet.2016.11.001
2
Jeremy Schofield, Sara Hosseinzadeh, Kieran Burton, Sue Pavord, Tina Dutt, Carolyn Doree, Wen Yuen Lim, Michael J. R. Desborough. Drug‐induced thrombotic thrombocytopenic purpura: A systematic review and review of European and North American pharmacovigilance dataBritish Journal of Haematology 2023; 201(4): 766 doi: 10.1111/bjh.18577
3
Hiroaki Morinaga, Tetsuro Miyazaki, Miyuki Tsutsui, Takatoshi Kasai, Atsutoshi Takagi, Kazunori Kajino, Katsumi Miyauchi, Hiroyuki Daida. Ischemic Cardiomyopathy with a Rapid Progression from Thrombotic Thrombocytopenic PurpuraInternal Medicine 2015; 54(18): 2351 doi: 10.2169/internalmedicine.54.4536
4
Nuccia Morici, Silvia Cantoni, Francesco Panzeri, Alice Sacco, Chiara Rusconi, Miriam Stucchi, Fabrizio Oliva, Marco Cattaneo. von Willebrand factor and its cleaving protease ADAMTS13 balance in coronary artery vessels: Lessons learned from thrombotic thrombocytopenic purpura. A narrative reviewThrombosis Research 2017; 155: 78 doi: 10.1016/j.thromres.2017.05.011